Nos actualités

Pharmaceuticals and Medical Device news
variété médicaments Cebiphar

FDA 2020: Still a promising year for small molecules

DRUG THERAPIES   In 2020, despite the COVID situation, the FDA approved different type of drug therapies, with the aim of improving the health of the population : New innovative drugs New uses or expansion of drugs already approved by the FDA Biosimilaires New formulations New dosage forms THE FUTURE OF SMALL MOLECULES Currently, the […]

Filter by category :
Filtrer par catégorie :
CEBIPHAR updates

WITH 94% OF CLIENT SATISFACTION...

As part of our sustainable customer experience program, a customer satisfaction survey was conducted in June 2021, aiming to build long-term relationships with our...
Read more
CEBIPHAR updates

CEBIPHAR awarded with a contract...

The French government recovery plan: Several pharma companies are focused on providing solutions to meet the needs of hospitals for essential drugs The pandemic...
Read more
CEBIPHAR updates

CEBIPHAR Toulouse : Opening of...

CEBIPHAR gets authorization from ANSM and ANSES for the opening of a pharmaceutical establishment on Toulouse site We are pleased to announce that after...
Read more
Pharmaceuticals and Medical Device news microbiological test Cebiphar

RELOCATION: The government plan and...

Et quia minima amet corporis sed dicta aperiam rerum excepturi cupiditate dolor fugit totam sed eaque quibusdam atque dolores molestiae id dicta eius asperiores...
Read more
Pharmaceuticals and Medical Device news variété médicaments Cebiphar

FDA 2020: Still a promising...

DRUG THERAPIES   In 2020, despite the COVID situation, the FDA approved different type of drug therapies, with the aim of improving the health...
Read more